Evidence map›Paper›PMID 40904649›Full record

ReviewDose-response : a publication of International Hormesis Society

High Natural Background Radiation Areas: A Literature Review that Reveals Systematic Adaptive Response but Controversial Data With Single Dose.

Juliette Restier-Verlet, Clément Devic, Camelia Bellemou, Michel Bourguignon, Nicolas Foray

Abstract readReview
In one paragraph

Review in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juliette Restier-VerletU1296 Unit (Radiation: Defense, Health and Environment), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.
Clément DevicCentre Antoine Lacassagne, Nice, France.
Camelia BellemouU1296 Unit (Radiation: Defense, Health and Environment), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.
Michel BourguignonU1296 Unit (Radiation: Defense, Health and Environment), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.
Nicolas ForayU1296 Unit (Radiation: Defense, Health and Environment), Institut National de la Santé et de la Recherche Médicale (INSERM), Lyon, France.ORCID https://orcid.org/0000-0002-1282-1303

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natural radiation background contributes to the dose of ionizing radiation received by the whole population. However, the telluric component of the natural background radiation is not homogenous on Earth: while the average effective dose has been estimated to be 2.4 mSv/year worldwide, certain regions are considered as high natural background radiation areas (HBRA). To investigate the specificities of a continuous exposure to low-dose-rate irradiation, we reviewed data of the major HBRA from 98 studies published between 1973 and 2023. Three conclusions were drawn: 1) the dose received by the HBRA inhabitants is much lower than values assessed on hot spots : at Ramsar (Iran), 260 mSv/year were assessed at the highest hotspots but the maximal estimated dose-rate received by inhabitants is 80 mSv/year; 2) when DNA or chromosome breaks, cancer or accelerated aging are used as endpoints, no significant difference was observed between cells from HBRA and non-HBRA inhabitants; 3) conversely, adaptive response effect was systematically observed on ex vivo lymphocytes from HBRA inhabitants when they are exposed to a high dose ranging for 0.25 to 4 Gy. A mechanistic model based on the radiation-induced nucleoshuttling of the ATM protein provides an explanation to these last two conclusions.

Indexed as

adaptive responseATM proteinhigh background radiation areashormesisindividual radiosensitivity

Identifiers

PMID40904649
PMCPMC12402632

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.